C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/81 (2006.01) A01K 67/00 (2006.01) A61K 38/16 (2006.01) A61K 38/55 (2006.01) C12N 15/85 (2006.01) C12P 21/02 (2006.01) C12N 15/12 (2006.01)
Patent
CA 2368608
The invention features transgenically produced mutants of Antithrombin III, e.g., transgenically produced mutants of ATIII having enhanced antiangiogenic activity. The invention also features methods of making mutants of ATIII, and transgenic organisms which express a mutated ATIII.
L'invention concerne des mutants de l'antithrombine III produits de manière transgénique, p. ex. des mutants d'ATIII produits de manière transgénique qui possèdent une activité anti-angiogénique accrue. L'invention concerne également des procédés de fabrication de mutants d'ATIII et des organismes transgéniques qui expriment une ATIII mutante.
Bourdon Paul R.
Meade Harry M.
Genzyme Transgenics Corp.
Gtc Biotherapeutics Inc.
Smart & Biggar
LandOfFree
Transgenically produced antithrombin iii and mutants thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transgenically produced antithrombin iii and mutants thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transgenically produced antithrombin iii and mutants thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1952022